BCAB
Bioatla Inc
NASDAQ: BCAB · HEALTHCARE · BIOTECHNOLOGY
$4.21
+4.21% today
Updated 2026-04-30
Market cap
$8.07M
P/E ratio
—
P/S ratio
4.04x
EPS (TTM)
$-50.50
Dividend yield
—
52W range
$4 – $72
Volume
1.0M
Bioatla Inc (BCAB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+26.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-3046.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-19.0%
2026-04-01
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-8.18 | — | $0.16 | $0.13 | -19.0% |
| 2026-03-19 | $0.00 | +100.0% | $0.16 | $0.17 | +5.4% |
| 2025-11-13 | $-0.27 | +1.2% | $0.69 | $0.79 | +14.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-8.18 | — | — | — |
| 2025-12-31 | $-0.30 | $0.00 | +100.0% | $2.00M | — |
| 2025-09-30 | $-0.27 | $-0.27 | +1.2% | — | — |
| 2025-06-30 | $-0.26 | $-0.32 | -23.1% | — | — |
| 2025-03-31 | $-0.29 | $-0.26 | +11.4% | — | — |
| 2024-12-31 | $-0.38 | $-0.30 | +21.1% | — | — |
| 2024-09-30 | $-0.36 | $-0.22 | +38.9% | $11.00M | — |
| 2024-06-30 | $-0.44 | $-0.44 | +0.0% | — | — |
| 2024-03-31 | $-0.54 | $-0.48 | +11.1% | — | — |
| 2023-12-31 | $-0.79 | $-0.56 | +29.0% | $1.71M | — |
| 2023-09-30 | $-0.80 | $-0.70 | +12.5% | — | — |
| 2023-06-30 | $-0.64 | $-0.75 | -17.2% | — | — |
Frequently asked questions
Has Bioatla Inc beaten earnings estimates?
Bioatla Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +26.0% over the last 3 quarters.
How does BCAB stock react to earnings?
BCAB stock has moved an average of +0.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.